Dysfunctional uterine bleeding, hereinafter referred to as gonorrhea, is abnormal uterine bleeding caused by the dysfunction of the reproductive endocrine axis, which is a common female reproductive endocrine disease. The treatment methods are as follows: 1. Anovulatory type of meritorious hemorrhage: Mostly seen in women in puberty and menopausal transition, also seen in women of childbearing age, mainly treated with drugs, mainly using sex hormones to stop bleeding and regulate the menstrual cycle. (1) Patients in adolescence and childbearing age: The main treatment is to stop bleeding, adjust the cycle, promote ovulation and prevent recurrence. For patients with coagulation or anemia, symptomatic treatment is needed along with hemostasis. After hemostasis, the menstrual cycle needs to be regulated to restore normal endocrine function, mostly by oral estrogen and progestin therapy to simulate the natural menstrual cycle, or oral contraceptive pills to prevent abnormal endometrial hyperplasia, which can be stopped after 3-6 months of continuous treatment. Patients need to pay attention to the regularity of life during the medication period, especially during the menstrual period to avoid stimulating the organism and prevent recurrence. Women with thrombotic diseases, high risk factors of cardiovascular diseases and smoking over 40 years old should not apply oral contraceptive treatment. For women of childbearing age who do not have fertility requirements can also consider the placement of a slow-release progestogen intrauterine birth control system, i.e., the Manned Ring. (2) Patients with menopausal transition: The main focus is to stop bleeding, adjust menstrual cycle, reduce menstrual flow and prevent endometrial lesions. For patients with poor drug effect, inappropriate to use drugs or can endometrial lesions, surgical treatment, such as endometrial removal and total hysterectomy, can be considered. 2.Ovulation type gonorrhea: Mostly seen in women of childbearing age, mainly caused by luteal insufficiency or luteal atrophy. For patients with luteal insufficiency, oral clomiphene can be used intermittently for 5 days from the 2nd to 5th day of menstruation to promote follicle development; oral or intramuscular progesterone can also be injected in the second half of the menstrual cycle. For patients with luteal atrophy, oral or intramuscular progestin supplementation can also be given during the second half of the menstrual cycle. Oral contraceptive pills can also be used to treat patients who do not have the need to have children. In summary, the treatment of dysfunctional uterine bleeding mainly uses sex hormones to stop bleeding and regulate the menstrual cycle, while adolescent and fertile patients also need ovulation restoration treatment.